Skip to main content

Table 1 Baseline Characteristics of Randomised participants

From: Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial

Characteristic

Study population (N = 27)

Age (yrs.)

24.5 (8.1)

Sex

 Female

10 (37%)

 Male

17 (63%)

Ethnic Origin

 Māori

4 (15%)

 NZ European

20 (74%)

 Other

3 (11%)

History of allergic rhinitis

14 (51.9%)

Body-mass indexa

24.6 (3.5)

FEV1 before bronchodilation (% predicted)

87.7 (10.6)

Peak Expiratory Flow (l/min)

443 (99)

FeNO (ppb)

87 (42–212)

Blood eosinophil count (× 10^9/L)

0.33 (0.18–1.18)

Blood eosinophil count ≥0.27 × 10^9/L

24 (88.9%)

Serum Periostin (ng/ml)

187.5 (109.4–442.5)

  1. Values are given as mean (SD), median (Range), or n (%). aThe body-mass index is the weight in kilograms divided by the square of the height in meters